Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2013,NCI,5F31CA165825-02,,Oncogenic cooperation restrained by a putative internal antagonist in miR-17-92,"SABIO, ERICH",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$34,791"
Lymphoma,2013,NCI,5R01CA100603-11,,Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer,"CLEVELAND, JOHN",SCRIPPS RESEARCH INSTITUTE,CA,"$392,303"
Lymphoma,2013,NCI,5R01CA080320-14,,Myc Oncogene Mutations and Polymorphisms in Cancer,"COLE, MICHAEL",DARTMOUTH COLLEGE,NH,"$316,569"
Lymphoma,2013,NCI,7R01CA077429-14,,Basis for Lymphomagenesis in Akt2 Transgenic Mice,"TESTA, JOSEPH",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$374,544"
Lymphoma,2013,NCI,5R01CA140806-04,,Proteomic biomarkers of ALK+ lymphoma,"LIM, MEGAN",UNIVERSITY OF MICHIGAN,MI,"$292,312"
Lymphoma,2013,NCI,5R01CA139389-04,,Lymphoma Therapy with Reprogrammed Measles Viruses,"CATTANEO, ROBERTO",MAYO CLINIC ROCHESTER,MN,"$285,880"
Lymphoma,2013,NCI,5R01CA052004-24,,Control of Gammaherpesvirus Replication,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$291,916"
Lymphoma,2013,NCI,5R01CA134674-04,,GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA,"CAMP, NICOLA",UNIVERSITY OF UTAH,UT,"$504,949"
Lymphoma,2013,NCI,5R01CA138891-04,,In vivo targeting of hematopoetic cells with glycan ligands of siglecs,"PAULSON, JAMES",SCRIPPS RESEARCH INSTITUTE,CA,"$354,146"
Lymphoma,2013,NIAID,5R01AI083453-04,,The NF-kB signaling system as a regulator of B-cell activation,"HOFFMANN, ALEXANDER",UNIVERSITY OF CALIFORNIA,CA,"$328,296"
Lymphoma,2013,NIAID,5R01AI079732-11,,Accessibility Control of Antigen Receptor Gene Assembly,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$350,092"
Lymphoma,2013,NCI,5R01CA096856-10,,Novel role of STAT3 in NPM/ALK-induced oncogenesis,"WASIK, MARIUSZ",UNIVERSITY OF PENNSYLVANIA,PA,"$272,958"
Lymphoma,2013,NCI,5R01CA137894-05,,EBV Antigen and Cell Cycle Regulation,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$268,189"
Lymphoma,2013,NCI,5P30CA016086-37,8689,Virology,"RAAB-TRAUB, NANCY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$160,148"
Lymphoma,2013,NCI,5P30CA016086-37,8690,Virology,"RAAB-TRAUB, NANCY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$170,078"
Lymphoma,2013,NCI,5R01CA136895-05,,Molecular targets in diffuse large B cell lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$236,120"
Lymphoma,2013,NCI,1F31CA171596-01,,STAT3: At the Crossroads of Inflammation and Cancer,"FOGLI, LAURA",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$32,342"
Lymphoma,2013,NCI,5R01CA131354-05,,Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$337,720"
Lymphoma,2013,NIEHS,5R01ES010807-13,,Molecular Mechanisms of Complex Mixture Toxicity,"PUGA, ALVARO",UNIVERSITY OF CINCINNATI,OH,"$442,974"
Lymphoma,2013,NCI,5R01CA085180-12,,Epstein-Barr Virus LMP1-Mediated Oncogenecity,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$659,320"
Lymphoma,2013,NCI,5R01CA114536-09,,Strategies to improve the adoptive transfer of T cells,"RIDDELL, STANLEY",FRED HUTCHINSON CAN RES CTR,WA,"$412,706"
Lymphoma,2013,NCI,5R01CA117830-08,,Regulation of KSHV Latency,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$278,661"
Lymphoma,2013,NCI,5R01CA138747-04,,microRNA-155 and Lymphoma,"AGUIAR, RICARDO","UNIV OF TX HSC, SA",TX,"$280,961"
Lymphoma,2013,NCI,5R01CA148950-03,,Regulation of Myc-Mediated Tumorigenesis,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY MED CTR,TN,"$304,016"
Lymphoma,2013,NCI,5R01CA102705-10,,Mismatch repair in V region mutation and isotype switching,"SCHARFF, MATTHEW",ALBERT EINSTEIN COLLEGE OF MEDICINE,NY,"$296,012"
Lymphoma,2013,NCI,5R01CA129330-05,,Origin of CD5+ B cell Lymphoma/Leukemia in Mice,"HAYAKAWA, KYOKO",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$337,720"
Lymphoma,2013,NCI,5R01CA129560-05,,Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas,"HAQUE, AZIZUL",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$279,069"
Lymphoma,2013,NCI,5R01CA095318-09,,Role of B Cells in Murine Gammaherpesvirus-68 Latency,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$310,947"
Lymphoma,2013,NCI,5R01CA139319-04,,The ARF Tumor Suppressor,"MURPHY, MAUREEN",WISTAR INSTITUTE,PA,"$325,422"
Lymphoma,2013,NCI,5R01CA102184-08,,Functional Analysis of p53 Polymorphic Variants,"MURPHY, MAUREEN",WISTAR INSTITUTE,PA,"$302,498"
Lymphoma,2013,NCI,5R01CA132840-05,,Function of REV3L in limiting oncogenesis via DNA damage tolerance,"WOOD, RICHARD",UT MD ANDERSON CANCER CTR,TX,"$291,367"
Lymphoma,2013,NCI,5R01CA142809-04,,Signal Transduction Pathways in CD30-positive Lymphomas,"DUCKETT, COLIN",UNIVERSITY OF MICHIGAN,MI,"$291,581"
Lymphoma,2013,NCI,5R01CA142664-04,,Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.,"YOTNDA, PATRICIA",BAYLOR COLLEGE OF MEDICINE,TX,"$290,421"
Lymphoma,2013,NCI,5R01CA143032-04,,Molecular Targeting of Diffuse Large B-cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$493,670"
Lymphoma,2013,NCI,5R01CA130988-05,,Regulation and function of IKKe in breast cancer initiation and maintenance,"HAHN, WILLIAM",DANA-FARBER CANCER INST,MA,"$313,646"
Lymphoma,2013,NCI,5R01CA142798-04,,The contribution of protein translation to tumorigenesis,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INST CAN RES,NY,"$359,478"
Lymphoma,2013,NIGMS,1SC3GM103713-01,,Characterization of novel compounds with anti-lymphoma activity,"AGUILERA, RENATO",UNIVERSITY OF TEXAS EL PASO,TX,"$113,125"
Lymphoma,2013,NIAID,5R21AI096000-02,,Role of Polycomb-mediated epigenetic regulation in diffuse large B cell lymphoma,"FEENEY, ANN",SCRIPPS RESEARCH INSTITUTE,CA,"$189,500"
Lymphoma,2013,NIGMS,1R01GM103843-01,,Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes,"YIN, HANG",UNIVERSITY OF COLORADO,CO,"$289,750"
Lymphoma,2013,NIAID,5R21AI099847-02,,Co-infection of mice with MHV68 and rodent Plasmodium species,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$232,500"
Lymphoma,2013,NHLBI,1R01HL116452-01,,The role of the SF3B1 splicing factor in chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$413,759"
Lymphoma,2013,NCI,1R01CA172582-01,,Alpha Radioimmunotherapy for Lymphoma Treatment,"SANDMAIER, BRENDA",FRED HUTCHINSON CAN RES CTR,WA,"$679,389"
Lymphoma,2013,NCI,1R01CA172492-01,,Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma,"PASQUALUCCI, LAURA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Lymphoma,2013,NIAID,5R21AI099386-02,,Stress Hormone-Mediated Reactivation of Latent Epstein-Barr Virus,"YANG, ERIC",OHIO STATE UNIVERSITY,OH,"$190,625"
Lymphoma,2013,NCI,5P30CA014236-39,6411,Hematopoietic Cell Transplantation and Hematologice Malignancies,"CHAO, NELSON",DUKE UNIVERSITY,NC,"$30,799"
Lymphoma,2013,NIAID,5R21AI092071-02,,Identification of a naturally occurring model for EBV-associated lymphomagenesis,"MASON, NICOLA",UNIVERSITY OF PENNSYLVANIA,PA,"$200,000"
Lymphoma,2013,NIBIB,5R01EB012569-03,,Multi-functional Nanocarrier against Canine Lymphoma,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$501,309"
Lymphoma,2013,NCI,1R03CA167752-01A1,,Alternative Cleavage and Polyadenylation Events as Biomarkers,"WAGNER, ERIC",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$76,000"
Lymphoma,2013,NCI,5R01CA104588-09,,RAG-induced DNA damage: mechanisms and responses,"ROTH, DAVID",UNIVERSITY OF PENNSYLVANIA,PA,"$258,325"
Lymphoma,2013,NCI,5R01CA164605-02,,Hdac3 as a therapeutic target in BCL6-dependent lymphoma,"HIEBERT, SCOTT",VANDERBILT UNIVERSITY MED CTR,TN,"$378,957"
Lymphoma,2013,NIAID,5R21AI094625-02,,IgM Fc receptor in CLL,"KUBAGAWA, HIROMI",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$183,125"
Lymphoma,2013,NIAID,5R43AI096588-02,,Development of a Small Molecule Inhibitor for EBV Latent Infection,"MCDONNELL, MARK","VIRONIKA, LLC",PA,"$91,124"
Lymphoma,2013,NCI,5R01CA154228-03,,Targeting vFLIP for the treatment of KSHV-associated malignancies,"CESARMAN, ETHEL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$329,635"
Lymphoma,2013,NCI,5R01CA140754-04,,Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort,"JOHNSON, CHRISTINE C",HENRY FORD HEALTH SYSTEM,MI,"$523,362"
Lymphoma,2013,NCI,5R01CA078384-15,,E2A as a Tumor Suppressor,"MURRE, CORNELIS",UNIVERSITY OF CALIFORNIA,CA,"$374,134"
Lymphoma,2013,NCI,5R01CA153260-14,,Control of Lineage Commitment in Developing Thymocytes,"KAPPES, DIETMAR",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$422,404"
Lymphoma,2013,NCI,5R01CA149707-04,,Investigating the functions of the miR-17~92 family of oncogenic microRNA cluster,"VENTURA, ANDREA",SLOAN-KETTERING INST CAN RES,NY,"$361,180"
Lymphoma,2013,NIAID,1R21AI103851-01,,Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir,"NICOT, CHRISTOPHE",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$188,750"
Lymphoma,2013,NIAID,5R21AI100319-02,,Biological consequences of a lymphoma-associated mutation in Ezh2 in mice,"FEENEY, ANN",SCRIPPS RESEARCH INSTITUTE,CA,"$284,250"
Lymphoma,2013,NCI,5R01CA154739-02,,Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics,"CLEVELAND, JOHN",SCRIPPS FLORIDA,FL,"$744,805"
Lymphoma,2013,NCI,5R01CA157660-02,,The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis,"KLEIN, ULF",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$310,161"
Lymphoma,2013,NIAMS,1R01AR063962-01A1,,CTCL immunobiology: lessons from alemtuzumab,"CLARK, RACHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$360,840"
Lymphoma,2013,NCI,2P01CA094237-11,6342,Engineering T Cells for Pancreatic Cancer,"LEEN, ANN",BAYLOR COLLEGE OF MEDICINE,TX,"$255,140"
Lymphoma,2013,NIAID,5R01AI077533-05,,Regulation of Immunity and Inflammation by TIPE2,"CHEN, YOUHAI",UNIVERSITY OF PENNSYLVANIA,PA,"$362,760"
Lymphoma,2013,NIDCR,5R01DE017336-08,,Epigenetic Regulation of Epstein-Barr Virus Latency Programs,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$304,538"
Lymphoma,2013,NCI,1R01CA166450-01A1,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2013,NCI,1R01CA166144-01A1,,Development of Therapeutic CD59 inhibitor for treating B-cell malignancies,"QIN, XUEBIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$119,146"
Lymphoma,2013,NIDCR,5R01DE019811-04,,Cell Penetrating Helical Peptide Inhibitors of vFLIP K13,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$373,366"
Lymphoma,2013,NCI,1R01CA165469-01A1,,Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,"BONDADA, SUBBARAO",UNIVERSITY OF KENTUCKY,KY,"$393,015"
Lymphoma,2013,NCI,1UM1CA173642-01,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CAN RES CTR,WA,"$1,894,768"
Lymphoma,2013,NIAID,5R01AI058057-09,,Function of the Gamma HV68 M2 Antigen,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$362,652"
Lymphoma,2013,NIDDK,5R01DK041876-25,,Mechanisms of Liver Cell Injury,"GORES, GREGORY",MAYO CLINIC ROCHESTER,MN,"$312,617"
Lymphoma,2013,NCI,1K99CA166181-01A1,,Specificity of the Ubiquitin System in Lymphoid Malignancies,"BUSINO, LUCA",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$90,000"
Lymphoma,2013,NCI,5R01CA165206-02,,CD19 Directed CAR Therapy,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$474,213"
Lymphoma,2013,NCI,5R21CA165923-02,,Robust rank-based methods and detection of GXE in cancer etiology and survival,"MA, SHUANGGE",YALE UNIVERSITY,CT,"$136,027"
Lymphoma,2013,NHLBI,5R01HL084353-08,,"Zfx, a novel transcriptional regulator of hematopoiesis","REIZIS, BORIS",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$379,174"
Lymphoma,2013,NCI,5R01CA151748-03,,Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$459,677"
Lymphoma,2013,NCI,5R01CA099997-10,,Mechanisms of Alteration of B Lymphocyte Function by LMP1,"BISHOP, GAIL",UNIVERSITY OF IOWA,IA,"$304,205"
Lymphoma,2013,NCI,6R01CA098285-10,,Towards a Mouse Model of Classical Hodgkin's Disease and PTLD,"ALT, FREDERICK",CHILDREN'S HOSPITAL CORPORATION,MA,"$457,564"
Lymphoma,2013,NCI,5R00CA134743-04,,"""Oncorequisite"" Genes in MYC-mediated Transformation","FENG, HUI",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$245,188"
Lymphoma,2013,NCI,5R01CA155226-03,,Targeting the heat shock response for the therapy of DLBCL,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$474,862"
Lymphoma,2013,NCI,5R01CA136591-05,,Role of the BCR in B Cell Chronic Lymphocytic Leukemia,"JELINEK, DIANE",MAYO CLINIC ROCHESTER,MN,"$285,880"
Lymphoma,2013,NCI,5R01CA158073-03,,The Role of ATM in Suppression of Lymphomas,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$312,080"
Lymphoma,2013,NCI,1R21CA169487-01A1,,Epigenomic determinants of clinical outcomes in MCL patients treated on E1405,"PAREKH, SAMIR",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$221,198"
Lymphoma,2013,NIAID,5R01AI084905-05,,Regulation of B cell development by the proto-oncogene LRF/Pokemon,"MAEDA, TAKAHIRO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$393,143"
Lymphoma,2013,NCI,5R01CA155143-03,,Predictors of clinical outcome after therapeutic vaccination in follicular lympho,"NEELAPU, SATTVA",UT MD ANDERSON CANCER CTR,TX,"$465,019"
Lymphoma,2013,NCI,5R01CA103642-10,,Immune surveillance in murine gammaherpesvirus infection,"USHERWOOD, EDWARD",DARTMOUTH COLLEGE,NH,"$259,585"
Lymphoma,2013,NCI,5R01CA058853-20,,Regulation of EBV Infection in Epithelial Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$267,781"
Lymphoma,2013,NCI,5R01CA167093-02,,Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis,"CLEVELAND, JOHN",SCRIPPS FLORIDA,FL,"$386,199"
Lymphoma,2013,NCI,5R01CA164152-02,,Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$312,080"
Lymphoma,2013,NCI,5R01CA133571-04,,Coordinately regulated alternative splicing in DNA damage and cancer,"CHANDLER, DAWN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$245,202"
Lymphoma,2013,NCI,5R01CA156674-03,,A Fourth Outcome: DNA Damage and the Differentiation of B Cells,"TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$295,991"
Lymphoma,2013,NCI,5R01CA138636-04,,BETR Therapy for Herpesvirus-Associated Tumors,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,$1
Lymphoma,2013,NCI,5R01CA068051-18,,Pathogenesis of EBV Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$423,802"
Lymphoma,2013,NCI,5R01CA137123-05,,Tageting BAFF and BAFF-Induced Non-Canonical NF-kB Pathways for Enhancing Mantle,"TAO, JIANGUO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$252,770"
Lymphoma,2013,OD,1S10OD016316-01,,Leica LMD 7000 Laser Capture Microdissection Microscope,"JANZ, SIEGFRIED",UNIVERSITY OF IOWA,IA,"$216,933"
Lymphoma,2013,NCI,7R01CA131024-05,,The Role of Methylthioadenosine Phosphorylase Loss in Tumorigenesis,"KRUGER, WARREN",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$337,720"
Lymphoma,2013,NCI,5U54CA149145-04,6611,COMPUTATIONAL ANALYSIS OF DIFFERENTIATION IN CANCER PROGRESSION,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$403,477"
Lymphoma,2013,NCI,5U54CA149145-04,6613,MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMA,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$170,140"
Lymphoma,2013,NCI,5U54CA149145-04,6614,MODELING THE ROLE OF DIFFERENTIATION IN T-ALL,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$154,358"
Lymphoma,2013,NCI,5R01CA154653-03,,Molecular epidemiology/functional analysis of microRNAs in Non-Hodgkin's lymphoma,"ZHU, YONG",YALE UNIVERSITY,CT,"$324,433"
Lymphoma,2013,NCI,5R01CA152923-03,,FLT-PET/CT for Therapy Monitoring of DLBCL,"QUON, ANDREW",STANFORD UNIVERSITY,CA,"$337,570"
Lymphoma,2013,NCI,7R21CA164469-02,,Molecular Programs for Stem Cells of Hematological Malignancies,"WANG, YIN",CHILDREN'S RESEARCH INSTITUTE,DC,"$175,827"
Lymphoma,2013,NINDS,5R21NS075509-02,,Osteopontin-mediated invasion and dissemination in central nervous system lymphom,"TUN, HAN",MAYO CLINIC  JACKSONVILLE,FL,"$186,969"
Lymphoma,2013,NCI,5U10CA047559-23,,Cancer and Leukemia Group B,"SHEA, THOMAS",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$144,968"
Lymphoma,2013,NCI,5R01CA113969-09,,RhoH GTPase in Hematopoiesis and Cancer,"WILLIAMS, DAVID",CHILDREN'S HOSPITAL CORPORATION,MA,"$306,016"
Lymphoma,2013,NCI,5R01CA136537-05,,Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia,"MALEK, SAMI",UNIVERSITY OF MICHIGAN,MI,"$291,182"
Lymphoma,2013,NCI,5R01CA088763-12,,LANA and Cellular Gene Expression,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$217,079"
Lymphoma,2013,NCI,5R01CA160256-02,,Temporal and Spatial Control of V(D)J Recombination,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$315,981"
Lymphoma,2013,NCI,5R01CA134807-04,,Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas,"SOTOMAYOR, EDUARDO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$425,222"
Lymphoma,2013,NCI,5F31CA167999-02,,Role of HSF1 in B cell activation and lymphoma,"FERNANDO, THARU",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$42,232"
Lymphoma,2013,NHLBI,5R01HL094603-04,,Chronic High EBV load and risk of PTLD in Pediatric Heart Transplant Patients,"METES, DIANA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$353,567"
Lymphoma,2013,NCI,2R44CA162582-02,,Reducing Complement Inhibition to Treat Leukemia and Lymphoma,"CARTER, DARRICK","PROTEIN ADVANCES, INC.",WA,"$833,191"
Lymphoma,2013,NCI,5P01CA109901-09,7134,Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy,"LOOK, A.",DANA-FARBER CANCER INST,MA,"$639,740"
Lymphoma,2013,NCI,5P01CA109901-09,7135,Molecular Pathways in T Cell Development and T-ALL,"VON BOEHMER, HARALD",DANA-FARBER CANCER INST,MA,"$189,839"
Lymphoma,2013,NCI,5P01CA109901-09,7136,The Molecular Function of D-cyclins in T-ALL,"SICINSKI, PETER",DANA-FARBER CANCER INST,MA,"$192,084"
Lymphoma,2013,NCI,5P01CA109901-09,7137,Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma,"ALT, FREDERICK","IMMUNE DISEASE INSTITUTE, INC.",MA,"$407,617"
Lymphoma,2013,NCI,5P01CA109901-09,7138,Epigenomic Changes in Normal T-cell Development and Leukemogenesis,"YOUNG, RICHARD",WHITEHEAD INSTITUTE FOR BIOMEDICAL RES,MA,"$377,438"
Lymphoma,2013,NCI,5P01CA109901-09,7139,Administrative Core,"LOOK, A.",DANA-FARBER CANCER INST,MA,"$47,311"
Lymphoma,2013,NCI,5P01CA109901-09,7140,Biostatistics and Bioinformatics Core,"NEUBERG, DONNA",DANA-FARBER CANCER INST,MA,"$41,368"
Lymphoma,2013,NCI,5R01CA113809-07,,Role of Missing Metastasis Gene in tumor progression,"ZHAN, STEVEN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$248,688"
Lymphoma,2013,NCI,5R01CA036725-28,,Immunotoxins in bone marrow transplantation,"VALLERA, DANIEL",UNIVERSITY OF MINNESOTA,MN,"$224,211"
Lymphoma,2013,NCI,1R43CA167972-01A1,,Minimal Residual Disease Monitoring by T-cell Receptor Repertoire Profiling,"RIEDER, MARK",ADAPTIVE TCR CORPORATION,WA,"$165,191"
Lymphoma,2013,NCI,5R01CA138268-05,,"Role of the cellular microRNA, miR-155, in EBV type III latency signaling","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$281,907"
Lymphoma,2013,NCI,5R01CA168558-02,,Cyclin requirements in gammaherpesvirus infection and disease,"VAN DYK, LINDA",UNIVERSITY OF COLORADO DENVER,CO,"$288,808"
Lymphoma,2013,NCI,5R01CA076445-13,,Studies of HHV-8 vIL-6 Function,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$328,590"
Lymphoma,2013,NIAID,5R01AI023283-28,,Molecular Basis of Immunoglobulin Heavy Chain Switch,"STAVNEZER, JANET",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$427,022"
Lymphoma,2013,NCI,1F30CA174172-01,,Oncolytic measles virus for combination radio-virotherapy in mantle cell lymphoma,"MIEST, TANNER",MAYO CLINIC ROCHESTER,MN,"$40,932"
Lymphoma,2013,NIGMS,5R01GM095606-03,,Coiled-coil Based Drug-Free Macromolecular Therapeutics,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$273,344"
Lymphoma,2013,NCI,1F32CA174247-01,,Antagonizing oncogenic microRNAs for the elucidation and treatment of lymphoma,"CHENG, CHRISTOPHER",YALE UNIVERSITY,CT,"$49,214"
Lymphoma,2013,NCI,1F30CA174232-01,,Combination therapies with interleukin-21 in chronic lymphocytic leukemia,"BROWNING, REBEKAH",OHIO STATE UNIVERSITY,OH,"$36,264"
Lymphoma,2013,NIAID,5R01AI101046-02,,Intercellular communication in Epstein Barr virus reactivation,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$353,675"
Lymphoma,2013,NCI,5F31CA167917-02,,Elucidating the in vivo Role of the p53 Apoptosis-Specific Target Gene Siva,"FREY, JEANINE",STANFORD UNIVERSITY,CA,"$42,232"
Lymphoma,2013,NHLBI,5R01HL079118-09,,Roles of Mre11 in Lymphocyte Development and DNA Repair,"FERGUSON, DAVID",UNIVERSITY OF MICHIGAN,MI,"$366,389"
Lymphoma,2013,NCI,5R01CA136905-05,,Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN,MI,"$260,080"
Lymphoma,2013,NCI,5R01CA160300-03,,Cellular Response to Short Telomeres in B-Cell Lymphoma,"GREIDER, CAROL",JOHNS HOPKINS UNIVERSITY,MD,"$491,013"
Lymphoma,2013,NIAID,5R01AI087634-04,,The Role of miR-17~92 in Autoimmune Diseases,"XIAO, CHANGCHUN",SCRIPPS RESEARCH INSTITUTE,CA,"$397,622"
Lymphoma,2013,NCI,5R01CA160556-03,,Escape from gammaherpesvirus-induced mRNA destruction,"GLAUNSINGER, BRITT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$292,208"
Lymphoma,2013,NCI,5P01CA078902-15,8825,Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations,"MALONEY, DAVID",FRED HUTCHINSON CAN RES CTR,WA,"$176,157"
Lymphoma,2013,NCI,5R01CA151955-04,,A bifunctional nanomedicine for both specific imaging and targeting therapy of an,"ZU, YOULI",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$291,367"
Lymphoma,2013,NCI,5R01CA109232-09,,Regulation of the KSHV Latent Promoter,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$220,337"
Lymphoma,2013,NCI,5R01CA166741-02,,Anticancer drug-induced BH3-only protein.Bak interactions,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$302,812"
Lymphoma,2013,NCI,5R01CA134241-06,,Post-Translational Events Underlying the KSHV vGPCR Pathogenesis,"FENG, PINGHUI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$310,286"
Lymphoma,2013,NCI,5R01CA115284-08,,KSHV RTA: more than viral replication,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$281,656"
Lymphoma,2013,NCI,5R01CA166219-02,,Molecular epidemiology of non-Hodgkin lymphoma prognosis and prevention,"WANG, SOPHIA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$625,398"
Lymphoma,2013,NCI,5R01CA151351-03,,Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy,"GALARDY, PAUL",MAYO CLINIC ROCHESTER,MN,"$317,594"
Lymphoma,2013,NCI,5R01CA162964-03,,Antibody-interferon fusion proteins for treatment of B-cell malignancies,"MORRISON, SHERIE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$300,377"
Lymphoma,2013,NCI,5R01CA158323-02,,Studies of Lymphoma Suppression and DNA Repair,"DU, CHUNYING",UNIVERSITY OF CINCINNATI,OH,"$306,229"
Lymphoma,2013,NCI,5U54CA112967-09,6516,Migration Networks,"GERTLER, FRANK",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$336,029"
Lymphoma,2013,NCI,5U54CA112967-09,6518,DNA Damage Networks,"YAFFE, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$281,250"
Lymphoma,2013,NCI,5R01CA154643-04,,Resequencing and Functional Studies to Identify Causal Gene Variants of Lymphoma,"SKIBOLA, CHRISTINE",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$582,094"
Lymphoma,2013,NCI,5R01CA151533-03,,Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma,"AMIN, HESHAM",UT MD ANDERSON CANCER CTR,TX,"$308,179"
Lymphoma,2013,NCI,5R01CA104348-09,,Transcriptional silencing by the BCL6 oncoprotein,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$235,282"
Lymphoma,2013,NCI,5R01CA149254-04,,Antibody-CpG conjugates for the treatment of B cell lymphoma,"TIMMERMAN, JOHN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$291,366"
Lymphoma,2013,NCI,5R01CA147791-04,,K-Rta as a Novel SUMO and Epigenetic Regulator,"IZUMIYA, YOSHIHIRO",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$291,367"
Lymphoma,2013,NCI,5R01CA090571-12,,"CRTC2 in Cellular Development, Function, and Neoplasia","TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$256,649"
Lymphoma,2013,NCI,5R01CA109335-08,,Significance and Function of HGAL in Lymphoma,"LOSSOS, IZIDORE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$228,585"
Lymphoma,2013,NCI,5R01CA155010-03,,Personal tumor neoantigens for immunity against chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$341,338"
Lymphoma,2013,NIBIB,5R01EB001994-14,,Imaging Based Dosimetry for Individualized Internal Emitter Therapy,"DEWARAJA, YUNI",UNIVERSITY OF MICHIGAN,MI,"$430,418"
Lymphoma,2013,NIDCR,5P01DE021954-03,5226,Cell Core,"BARCY, SERGE",SEATTLE CHILDREN'S HOSPITAL,WA,"$168,033"
Lymphoma,2013,NCI,5P01CA090890-09,6522,Transplacental Chemoprevention of Lung Tumors and Lymphomas,"WILLIAMS, DAVID",OREGON STATE UNIVERSITY,OR,"$216,948"
Lymphoma,2013,NCI,5R01CA072649-15,,Somatic Mutation of IG Variable Regions,"SCHARFF, MATTHEW",ALBERT EINSTEIN COLLEGE OF MEDICINE,NY,"$371,121"
Lymphoma,2013,NCI,5R01CA153248-04,,Enhancing tumor-targeted antibody therapy with a second NK activating antibody.,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$244,457"
Lymphoma,2013,NCI,5P30CA015083-39,5790,Biospeciman,"HIGHSMITH, WILLIAM",MAYO CLINIC ROCHESTER,MN,"$159,544"
Lymphoma,2013,NCI,5P30CA086862-13,8601,Cancer Immunology and Immunotherapy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$48,003"
Lymphoma,2013,NCI,5P30CA086862-13,8684,Protocol Specific Research Support,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$50,480"
Lymphoma,2013,NIAID,1U01AI104342-01,,Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children,"ESQUIVEL, CARLOS",STANFORD UNIVERSITY,CA,"$1,363,549"
Lymphoma,2013,NCI,1R21CA171937-01A1,,Inhibitory targeting of HHV-8 vIL-6-related interactions.,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$176,175"
Lymphoma,2013,NCI,1R01CA168482-01A1,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2013,NCI,5U54CA148967-04,6640,Endogenous Heterogeneity of Signaling Pathways in Cancer,"ALTAN-BONNET, GREGOIRE",SLOAN-KETTERING INST CAN RES,NY,"$418,933"
Lymphoma,2013,NCI,5U10CA016116-40,,Eastern Cooperative Oncology Group,"FORASTIERE, ARLENE",JOHNS HOPKINS UNIVERSITY,MD,"$227,541"
Lymphoma,2013,NIAID,5R01AI081710-04,,Mechanisms of KSHV post-transcriptional gene regulation,"CONRAD, NICHOLAS",UT SOUTHWESTERN MEDICAL CENTER,TX,"$353,948"
Lymphoma,2013,NCI,5P30CA006516-48,6047,Lymphoma and Myeloma,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$85,506"
Lymphoma,2013,NCI,5U10CA013650-41,,Eastern Cooperative Oncology Group,"HABERMANN, THOMAS",MAYO CLINIC ROCHESTER,MN,"$176,112"
Lymphoma,2013,NCI,5R01CA132098-05,,HDAC Inhibitors and CTCL,"SHOWE, LOUISE",WISTAR INSTITUTE,PA,"$390,140"
Lymphoma,2013,NIAID,5R01AI067968-07,,Role and mechanism of action of gamma herpesvirus microRNAs,"CULLEN, BRYAN",DUKE UNIVERSITY,NC,"$368,950"
Lymphoma,2013,NHGRI,5U01CA168426-02,,Systems Biology of Tumor Progression and Drug Resistance,"CALIFANO, ANDREA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$1,107,785"
Lymphoma,2013,NHLBI,5R01HL103532-04,,Post-transplant vaccines to enhance graft-versus-leukemia responses,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$412,335"
Lymphoma,2013,NIEHS,5R01ES020116-04,,Epigenomic profiling of histone turnover kinetics in mammalian cells,"HENIKOFF, STEVEN",FRED HUTCHINSON CAN RES CTR,WA,"$471,673"
Lymphoma,2013,NCI,5R01CA154674-02,,Cotranslational Functions of MTOR,"JACINTO, ESTELA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,$1
Lymphoma,2013,NCI,5P30CA124435-07,6484,Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$14,100"
Lymphoma,2013,NCI,5P30CA124435-07,6543,Hematopoetic,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$14,100"
Lymphoma,2013,NCI,2P01CA049605-24A1,5891,Immune Regulation in HCT,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$1,151,706"
Lymphoma,2013,NCI,2P01CA049605-24A1,5892,Auto-lmmunotransplantation for Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$199,529"
Lymphoma,2013,NCI,2P01CA049605-24A1,5893,Memory CDS T Cells for GVL,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$150,528"
Lymphoma,2013,NCI,2P01CA049605-24A1,5894,Improving Graft-versus-Leukemia Alloimmunity against CLL,"MIKLOS, DAVID",STANFORD UNIVERSITY,CA,"$135,776"
Lymphoma,2013,NCI,2P01CA049605-24A1,5897,Administration and Clinical Trial Coordination,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$258,743"
Lymphoma,2013,NCI,2P01CA049605-24A1,5898,Biostatistics and Data Management,"LAVORI, PHILIP",STANFORD UNIVERSITY,CA,"$186,995"
Lymphoma,2013,NCI,2P01CA049605-24A1,5899,Molecular Diagnostics,"ZEHNDER, JAMES",STANFORD UNIVERSITY,CA,"$239,458"
Lymphoma,2013,NCI,2P01CA049605-24A1,5900,Cell Processing and Sample Distribution Laboratory,"LOWSKY, ROBERT",STANFORD UNIVERSITY,CA,"$377,265"
Lymphoma,2013,NCI,5P01CA016038-40,7648,Biology of the Epstein-Barr Virus R Transactivator in Human B Cells,"MILLER, I.",YALE UNIVERSITY,CT,"$349,372"
Lymphoma,2013,NCI,5P01CA016038-40,7650,"Viral RNPs, mRNA Stability and Export","STEITZ, JOAN",YALE UNIVERSITY,CT,"$162,241"
Lymphoma,2013,NCI,5R01CA139083-05,,The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's Lymphoma,"RUBENSTEIN, JAMES",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$291,356"
Lymphoma,2013,NCI,5R37CA031845-33,,Synthetic Studies Related to Cancer Research/Treatment,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$420,573"
Lymphoma,2013,NCI,1R01CA174794-01,,Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation,"KRULL, KEVIN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$544,189"
Lymphoma,2013,NCI,1U01CA174844-01,,A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia,"RADER, CHRISTOPH",SCRIPPS FLORIDA,FL,"$479,542"
Lymphoma,2013,NHLBI,5U10HL108945-03,,Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,"$160,218"
Lymphoma,2013,NHLBI,5U10HL069233-13,,Nebraska/Kansas Blood and Marrow Transplant Research Network,"VOSE, JULIE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$154,372"
Lymphoma,2013,NCI,5K08CA158069-03,,The Role of Heme Metabolic Pathways in T Cell Development and T Cell Lymphomagene,"PHILIP, MARY",UNIVERSITY OF WASHINGTON,WA,"$167,400"
Lymphoma,2013,NCI,2R01CA091791-11A1,,Reactivation of Kaposi's Sarcoma-Associated Herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$284,547"
Lymphoma,2013,NHLBI,5U10HL109322-03,,The Ohio State Blood and Marrow Transplant Reseach Consortium,"DEVINE, STEVEN",OHIO STATE UNIVERSITY,OH,"$151,220"
Lymphoma,2013,NIAID,2R01AI069943-06A1,,T cell function in murine gammaherpesvirus infection,"USHERWOOD, EDWARD",DARTMOUTH COLLEGE,NH,"$285,232"
Lymphoma,2013,NCI,1R21CA175461-01,,Role of IRF4-NOTCH2 Interplay in B-Cell Development and Malignancy,"KLEIN, ULF",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$208,800"
Lymphoma,2013,NCI,1R21CA175560-01,,A new technology to isolate RNP complexes of a polycistronic miRNA oncogene,"HE, LIN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$166,256"
Lymphoma,2013,NHLBI,5R01HL095120-06,,The Role of Zinc Finger Genes in Leukemogenesis,"DOVAT, SINISA",PENNSYLVANIA STATE UNIVERSITY,PA,"$359,674"
Lymphoma,2013,NCI,5R01CA107106-08,,Assays for Screening Histone Modifications in Cancer,"FREITAS, MICHAEL",OHIO STATE UNIVERSITY,OH,"$213,136"
Lymphoma,2013,NCI,1R21CA176362-01,,Defining molecular biomarkers for CDK4/6-based cancer therapy by RNA sequencing,"CHEN-KIANG, SELINA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$220,545"
Lymphoma,2013,NIAID,5R21AI097540-02,,Role of ROS and Nrf2 in HHV-8 infection and pathogenesis,"BOTTERO, VIRGINIE",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$181,538"
Lymphoma,2013,NCI,5K05CA160724-03,,Survivorship: Mentoring and Bridging Primary Care and Oncology,"OEFFINGER, KEVIN",SLOAN-KETTERING INST CAN RES,NY,"$164,278"
Lymphoma,2013,NCI,5K23CA160345-03,,Targeting Akt Activation in CLL,"DING, WEI",MAYO CLINIC ROCHESTER,MN,"$167,400"
Lymphoma,2013,NCI,5R01CA136907-05,,Targeting the proteasome to overcome therapy resistance in B-NHL,"CZUCZMAN, MYRON",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$342,247"
Lymphoma,2013,NIAID,5R01AI078267-05,,Transcriptional Control of Hematopoiesis,"KEE, BARBARA",UNIVERSITY OF CHICAGO,IL,"$359,305"
Lymphoma,2013,NCI,5R21CA171814-02,,Targeting Kinases that Phosphorylate the KSHV LANA Chromatin Binding Domain,"HAYWARD, S",JOHNS HOPKINS UNIVERSITY,MD,"$165,605"
Lymphoma,2013,NIAID,5R01AI072194-05,,ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INST CAN RES,NY,"$436,694"
Lymphoma,2013,NIAID,5P01AI076210-05,8138,Role of SAP (SH2D1A) gene in T cell-dependent antibody response,"TERHORST, CORNELIS",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$272,566"
Lymphoma,2013,NIAID,5P01AI076210-05,8139,Role of TACI mutations in CVID,"GEHA, RAIF",CHILDREN'S HOSPITAL CORPORATION,MA,"$471,427"
Lymphoma,2013,NHLBI,5K01HL103182-04,,The Role of hPso4 in DNA Repair and Chemotherapy Resistance,"SHAHEEN, MONTASER",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$135,657"
Lymphoma,2013,NIAID,5R21AI095180-02,,PREVENTION AND ANTIVIRAL TREATMENT FOR EBV LYMPHOMAGENESIS,"PAGANO, JOSEPH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$178,600"
Lymphoma,2013,NHLBI,5R01HL115761-02,,Targeting CCR7 for the Prevention/Treatment of GvHD,"SERODY, JONATHAN",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$352,240"
Lymphoma,2013,NCI,2R01CA063417-13A1,,PROLIFERATIVE EFFECTS OF HTLV-1,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$158,641"
Lymphoma,2013,NCI,2R01CA070723-16A1,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN-MADISON,WI,"$304,213"
Lymphoma,2013,NIAID,2R01AI076183-11,,Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$490,755"
Lymphoma,2013,NCI,1U01CA166905-01A1,,Identifying non-coding RNAs for early detection and prevention of lung cancer,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$967,089"
Lymphoma,2013,NCI,2R01CA129037-06A1,,Replicative senescence as a tumor suppressive mechanism,"CHANG, SANDY",YALE UNIVERSITY,CT,"$306,706"
Lymphoma,2013,NCI,5R37CA049870-26,,Antibody V Gene Expression B Cell Lymphocytic Leukemia,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA,CA,"$296,510"
Lymphoma,2013,NCI,5K08CA140780-04,,Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB,"GEWURZ, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$179,910"
Lymphoma,2013,NCI,5U01CA157581-03,,Molecular Diagnosis and Prognosis in Aggressive Lymphoma,"RIMSZA, LISA",UNIVERSITY OF ARIZONA,AZ,"$460,703"
Lymphoma,2013,NCI,5P01CA019014-34,6231,DNA-Protein Interactions in Herpes Viruses,"GRIFFITH, JACK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$254,304"
Lymphoma,2013,NCI,5P01CA019014-34,6234,Cellular Reprogramming by KSHV Latent Genes and miRNAs,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$273,796"
Lymphoma,2013,NCI,5P01CA019014-34,6235,Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2),"RAAB-TRAUB, NANCY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$273,889"
Lymphoma,2013,NCI,5R01CA140337-03,,Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$306,229"
Lymphoma,2013,NCI,1R01CA164641-01A1,,Natural Killer Cell Regulation by PRDM1 and IRF4/8,"WRIGHT, KENNETH",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$314,674"
Lymphoma,2013,NCI,1R01CA170023-01A1,,Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$365,632"
Lymphoma,2013,NIEHS,1R01ES021832-01A1,,Endocrine disrupter modulation of SXR in development and lymphomagenesis,"BLUMBERG, BRUCE",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$346,313"
Lymphoma,2013,NCI,5R01CA161026-03,,Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$402,341"
Lymphoma,2013,NCI,5R01CA047006-26,,Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$531,318"
Lymphoma,2013,NCI,5R01CA166325-02,,Mechanisms promoting translocations and mature B cell lymphomas,"WANG, JING",UNIVERSITY OF COLORADO DENVER,CO,"$306,064"
Lymphoma,2013,NCI,5R01CA149445-03,,A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma,"BIRMANN, BRENDA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$560,228"
Lymphoma,2013,NCI,1K23CA154874-01A1,,Optimization of adoptive immunotherapy with autologous CD20-specific T cells,"TILL, BRIAN",FRED HUTCHINSON CAN RES CTR,WA,"$171,720"
Lymphoma,2013,NCI,5K08CA134919-03,,Molecular Pathogenesis of Monoclonal B Cell Lymphocytosis and CLL,"LANASA, MARK",DUKE UNIVERSITY,NC,"$161,137"
Lymphoma,2013,NCI,5R33CA161731-03,,Validating a novel biomarker of clinical progression and survival in CLL,"DAVIS, RANDALL",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$364,740"
Lymphoma,2013,NCI,5R01CA163217-03,,Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$287,409"
Lymphoma,2013,NIAID,1R21AI105909-01,,KSHV vaccine development,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$205,000"
Lymphoma,2013,NCI,1R03CA156561-01A1,,Clinical characteristics and patterns of care for rare brain tumor sub-types,"VILLANO, JOHN",UNIVERSITY OF KENTUCKY,KY,"$86,578"
Lymphoma,2013,NCI,5K08CA140718-05,,Regulation and Dysregulation of Antibody Diversification,"STROUT, MATTHEW",YALE UNIVERSITY,CT,"$174,420"
Lymphoma,2013,NCI,5F31CA150546-04,,p53-independent function of Mdmx in tumorigenesis,"MELO, ALEXIA",VANDERBILT UNIVERSITY MED CTR,TN,"$26,837"
Lymphoma,2013,NCI,5U54CA155496-03,5936,Social Determinants in the Link between Obesity and Cancer,"HOVMAND, PETER",WASHINGTON UNIVERSITY IN ST LOUIS,,"$210,691"
Lymphoma,2013,NCI,2P01CA022443-36,6859,Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,"MERTZ, JANET",UNIVERSITY OF WISCONSIN-MADISON,WI,"$258,881"
Lymphoma,2013,NCI,2P01CA022443-36,6863,miRNA and v-Cdks: Independent Drivers OF EBV and HCMV Replication and Oncogenesi,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$294,254"
Lymphoma,2013,NIAID,2R01AI018757-31,,Host Immunity to EBV Infection in Vitro and in Vivo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$387,750"
Lymphoma,2013,NCI,1R03CA176768-01,,Lifestyle Factors and Lymphoma: An Asia Cohort Consortium Pooling Project,"CHIU, BRIAN",UNIVERSITY OF CHICAGO,IL,"$100,161"
Lymphoma,2013,NCI,1R03CA171052-01A1,,Identification of Novel Viruses Associated with Malignant Diseases,"SALYAKINA, DARIA",UNIVERSITY OF MIAMI CORAL GABLES,FL,"$69,816"
Lymphoma,2013,NCI,5R01CA151319-03,,TOWARD AN UNDERSTANDING OF CLL PROGRESSION,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$352,327"
Lymphoma,2013,NCI,5R01CA102667-09,,Effects of Malaria on EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$296,971"
Lymphoma,2013,NCI,5R01CA159296-02,,Novel Immunotherapies for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$297,452"
Lymphoma,2013,NHLBI,5R01HL116217-02,,Engraftment and in vivo selection of HIV-protected stem cells,"KIEM, HANS-PETER",FRED HUTCHINSON CAN RES CTR,WA,"$769,503"
Lymphoma,2013,NCI,5R01CA151899-03,,Communication Skills Intervention to Promote Transition into Survivorship,"HORWITZ, STEVEN",SLOAN-KETTERING INST CAN RES,NY,"$560,995"
Lymphoma,2013,NCI,5R21CA158686-02,,Biological Variants Underlying Racial Differences in Lymphoma,"FLOWERS, CHRISTOPHER",EMORY UNIVERSITY,GA,"$190,284"
Lymphoma,2013,NIAAA,5R01AA017972-05,,Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,"GARTENHAUS, RONALD",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$315,273"
Lymphoma,2013,NCI,5P30CA125123-07,6427,PROGRAM LEADERS,"OSBORNE, C",BAYLOR COLLEGE OF MEDICINE,TX,"$80,753"
Lymphoma,2013,NCI,5P30CA125123-07,6486,HUMAN TISSUE ACQUISITION AND PATHOLOGY,"AYALA, GUSTAVO",BAYLOR COLLEGE OF MEDICINE,TX,"$196,146"
Lymphoma,2013,NCI,5P30CA125123-07,6609,Program leaders---cell and gene therapy,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$57,350"
Lymphoma,2013,NIDDK,5R01DK043726-22,,Biological functions and mechanisms of action of Ikaros proteins,"SMALE, STEPHEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$323,228"
Lymphoma,2013,NCI,5R21CA164911-02,,Novel Biomarkers in Cutaneous T Cell Lymphoma,"WONG, HENRY",OHIO STATE UNIVERSITY,OH,"$155,893"
Lymphoma,2013,NCI,5K23CA140722-04,,Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma,"FAN, ALICE",STANFORD UNIVERSITY,CA,"$173,448"
Lymphoma,2013,NCI,5R01CA140245-04,,Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction,"PALOMARES, MELANIE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$571,394"
Lymphoma,2013,NCI,5R01CA156690-04,,TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$284,934"
Lymphoma,2013,RMAP,5R01CA156690-04,,TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$300,089"
Lymphoma,2013,NCI,5R01CA117794-08,,Inhibitors of the Epstein-Barr Virus Entry Machinery,"JARDETZKY, THEODORE",STANFORD UNIVERSITY,CA,"$311,336"
Lymphoma,2013,NCI,5K01CA138559-05,,Antibody-mediated Gene Therapy for the Treatment of Cancer,"DANIELS-WELLS, TRACY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$142,677"
Lymphoma,2013,NCI,5P30CA091842-12,6584,Hematopoietic Developmental Malignancy,"LINK, DANIEL",WASHINGTON UNIVERSITY,MO,"$60,202"
Lymphoma,2013,NCI,5P50CA140158-05,5397,Early Predisposing Genes and Risk Stratification for CLL,"DE LA CHAPELLE, ALBERT",OHIO STATE UNIVERSITY,OH,"$273,245"
Lymphoma,2013,NCI,5P50CA140158-05,5399,Lenalidomide as an Immune Modulating Agent for Chronic Lymphocytic Leukemia,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$230,527"
Lymphoma,2013,NCI,5P50CA140158-05,5401,Pre-Clinical and Clinical Development of Silvestrol in Chronic Lymphocytic,"GREVER, MICHAEL",OHIO STATE UNIVERSITY,OH,"$251,385"
Lymphoma,2013,NIGMS,2R44GM096494-02A1,,Using Aldehyde Tags to Generate Site-Specifically Modified Antibody Drug Conjugat,"RABUKA, DAVID","REDWOOD BIOSCIENCE, INC.",CA,"$530,315"
Lymphoma,2013,NCI,5K24CA125440-07,,Clinical and Molecular Studies of Malignant Brain Tumors,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$185,972"
Lymphoma,2013,NHLBI,5F30HL107139-03,,The role of ADAM10 in B cell development and humoral immunity,"CHAIMOWITZ, NATALIA",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$39,881"
Lymphoma,2013,NIAID,5P01AI061093-10,7981,Investigating Blocks to B Cell Memory in CVID,"CUNNINGHAM-RUNDLES, CHARLOTTE",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$300,302"
Lymphoma,2013,NCI,1F32CA177139-01,,The Role of CD4+ T Cells in Oncogene Addiction,"CASEY, STEPHANIE",STANFORD UNIVERSITY,CA,"$49,214"
Lymphoma,2013,NCI,1F31CA177092-01,,Cyclin D3 and DNA double strand breaks: genome stability and lymphomagenesis,"DEMICCO, AMY",UNIVERSITY OF PENNSYLVANIA,PA,"$42,232"
Lymphoma,2013,NCI,1F31CA171532-01A1,,Identifying Regulators of Oncogenic CARD11 in Diffuse Large B Cell Lymphoma,"MACKIE, DEMAURI",JOHNS HOPKINS UNIVERSITY,MD,"$42,232"
Lymphoma,2013,NCI,5F31CA171677-02,,Characterization and Development of a Coiled-Coil to Treat Non-Hodgkin Lymphoma,"JACOBSEN, MICHAEL",UNIVERSITY OF UTAH,UT,"$42,232"
Lymphoma,2013,NIAID,5R01AI078234-05,,New Strategies to Decipher the Pathophysiology of Chronic Fatigue Syndrome,"LOMBARDI, VINCENT",WHITTEMORE PETERSON INSTITUTE,NV,"$284,693"
Lymphoma,2013,NCI,5R01CA164311-02,,MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm,"EVENS, ANDREW",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$333,037"
Lymphoma,2013,NCI,1R01CA162411-01A1,,Novel monocyte effector function in CLL immune therapy,"TRIDANDAPANI, SUSHEELA",OHIO STATE UNIVERSITY,OH,"$317,993"
Lymphoma,2013,NCI,5K05CA136967-05,,Research and Mentoring on Energetic Factors and Cancer: Established Investigator,"BERNSTEIN, LESLIE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$139,821"
Lymphoma,2013,NCI,5R01CA164346-02,,CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF,"YOU, M. JAMES",UT MD ANDERSON CANCER CTR,TX,"$282,001"
Lymphoma,2013,NCI,1R01CA177292-01,,Targeted Therapy for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$534,094"
Lymphoma,2013,NCI,5R21CA162278-02,,Cancer Cell Overexpression of Death Receptor Modulator,"SAMANIEGO, FELIPE",UT MD ANDERSON CANCER CTR,TX,"$161,516"
Lymphoma,2013,NCI,5R01CA164679-02,,HVEM-BTLA Pathway in Lymphoma,"WARE, CARL",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$380,348"
Lymphoma,2013,NCI,5U01CA118444-08,,Genetic Epidemiology of Chronic Lymphocytic Leukemia,"SLAGER, SUSAN",MAYO CLINIC ROCHESTER,MN,"$580,830"
Lymphoma,2013,NCI,5K08CA133521-05,,Role of B-cell oncogenes and microRNA-34 in B-lymphopoiesis and neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$158,893"
Lymphoma,2013,NCI,5K07CA140360-04,,"Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma","HUSSAIN, SHEHNAZ",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$125,208"
Lymphoma,2013,NCI,5U54CA143874-05,5002,Deconvoluting Ras Signaling Networks in T Cell Lymphoma,"CHAKRABORTY, ARUP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$406,275"
Lymphoma,2013,NIAID,1R01AI106393-01,,BH3-only protein targeting by HHV-8,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$380,700"
Lymphoma,2013,NCI,5R01CA085563-11,,"ROS, Redox Regulation and Novel Targets for Cancer Therapy","HUANG, PENG",UT MD ANDERSON CANCER CTR,TX,"$219,564"
Lymphoma,2013,NCI,5R00CA140728-04,,Immunotransplant to Mantle Cell Lymphoma: Immune Response and Clinical Outcomes,"BRODY, JOSHUA",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$249,000"
Lymphoma,2013,NCI,5U54CA143907-05,8456,Dynamic State Space Modeling of Cancer Cell Response to Therapy,"NOLAN, GARRY",STANFORD UNIVERSITY,CA,"$1,118,441"
Lymphoma,2013,NCI,5U54CA143907-05,8458,Multi-Scale Cancer Modeling: From Cell Phenotypes to Cancer Spread and Response,"CRISTINI, VITTORIO",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$335,119"
Lymphoma,2013,NCI,1R01CA177319-01,,The Role of NOTCH1 in the Pathogenesis of CLL.,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$358,315"
Lymphoma,2013,NCI,5P01CA047741-20,8056,Clinical Trials of Haploidentical Hematopoietic Stem Cell Transplantation and Vac,"CHAO, NELSON",DUKE UNIVERSITY,NC,"$888,668"
Lymphoma,2013,NCI,5R01CA103646-07,,Modeling KSHV latency in vivo,"CESARMAN, ETHEL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$308,788"
Lymphoma,2013,NCI,5R01CA158402-02,,Molecular mechanisms of B cell malignant transformation,"XIE, PING",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$303,108"
Lymphoma,2013,NCI,5R01CA163587-02,,IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY,"COOPER, LAURENCE",UT MD ANDERSON CANCER CTR,TX,"$575,114"
Lymphoma,2013,OD,1R21CA177315-01,,Pathobiology and Clinical Profile of HIV-Associated Cancers in India and the West,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$206,901"
Lymphoma,2013,NCI,5F32CA165705-02,,Effects of short-chain fatty acids on Epstein-Barr virus in B cell lymphoma,"GORRES, KELLY",YALE UNIVERSITY,CT,"$53,942"
Lymphoma,2013,NCI,5F31CA171933-02,,Characterization of ER-localized Activity of HHV-8 Interleukin-6,"COUSINS, EMILY",JOHNS HOPKINS UNIVERSITY,MD,"$42,232"
Lymphoma,2013,NCI,7U01CA105492-10,,Using mouse models to probe the relationship of oncogenesis to development and o,"HOLLAND, ERIC",FRED HUTCHINSON CAN RES CTR,WA,"$664,043"
Lymphoma,2013,NCI,1P01CA174439-01A1,8216,Role of LANA-RBP-jk During Early KSHV Infection,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$385,753"
Lymphoma,2013,NCI,1P01CA174439-01A1,8218,Chromatin Regulation of KSHV Primary Infection,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$401,745"
Lymphoma,2013,NCI,1R01CA174462-01A1,,New Models and Treatments for AIDS-related Lymphoma,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$416,873"
Lymphoma,2013,NCI,1R13CA177329-01,,"Conference Support for 16th International Workshop on KSHV and Related Agents, Pu","CHANDRAN, BALA",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$7,000"
Lymphoma,2013,NCI,2R01CA124332-07,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$302,252"
Lymphoma,2013,NCI,5R01CA129974-07,,Probing mitochondria and personalizing leukemia therapy with BH3 profiling,"LETAI, ANTHONY",DANA-FARBER CANCER INST,MA,"$296,244"
Lymphoma,2013,NCI,5K99CA157954-02,,Convergence of CREB and MYC Pathways in Oncogenesis.,"AMELIO, ANTONIO",SCRIPPS FLORIDA,FL,"$147,150"
Lymphoma,2013,NCI,5R01CA165937-02,,Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons,"SILVERBERG, MICHAEL",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$570,918"
Lymphoma,2013,NCI,5R01CA168477-02,,Immune Modulation by Gammaherpesviruses,"COSCOY, LAURENT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$243,962"
Lymphoma,2013,NCI,5F31CA165728-02,,Novel Mechanism for Myc-Induced Apoptosis,"ADAMS, CLARE",VANDERBILT UNIVERSITY MED CTR,TN,"$26,592"
Lymphoma,2013,NCI,5P01CA044991-25,8453,Radioimmunotherapy for Lymphoma,"GOPAL, AJAY",FRED HUTCHINSON CAN RES CTR,WA,"$256,316"
Lymphoma,2013,NCI,5P01CA044991-25,8454,Pretargeted Radioimmunotherapy for Hematologic Malignancies,"PRESS, OLIVER",FRED HUTCHINSON CAN RES CTR,WA,"$301,631"
Lymphoma,2013,NCI,5P01CA044991-25,8455,Administrative and Statistical Core,"PRESS, OLIVER",FRED HUTCHINSON CAN RES CTR,WA,"$425,610"
Lymphoma,2013,NCI,5P01CA044991-25,8456,Nuclear Medicine Core,"RAJENDRAN, JOSEPH",FRED HUTCHINSON CAN RES CTR,WA,"$589,695"
Lymphoma,2013,NCI,5P01CA044991-25,8457,Biologics Production Core,"BALDWIN, JANELL",FRED HUTCHINSON CAN RES CTR,WA,"$251,610"
Lymphoma,2013,NCI,5P01CA128115-05,7661,Host Defense Regulation by HTLV-1,"ROSENBLATT, JOSEPH",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$230,653"
Lymphoma,2013,NCI,5K08CA151450-04,,Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma,"LABELLE, JAMES",UNIVERSITY OF CHICAGO,IL,"$168,048"
Lymphoma,2013,NCI,1R01CA177423-01,,KSHV genome modification in KS tissue,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$200,000"
Lymphoma,2013,NCI,5P50CA126752-07,0001,T CELL THERAPY TARGETING MULTIPLE TUMOR ANTIGENS IN HODGKIN LYMPHOMA,"LEEN, ANN",BAYLOR COLLEGE OF MEDICINE,TX,"$234,786"
Lymphoma,2013,NCI,5P50CA126752-07,0002,CHIMERIC T CELL ANTIGENS TARGETING IG KAPPA LIGHT CHAIN IN B CELL LYMPHOMA,"DOTTI, GIANPIETRO",BAYLOR COLLEGE OF MEDICINE,TX,"$220,788"
Lymphoma,2013,NCI,5P50CA126752-07,0003,BUILDING ON SUCCESSFUL T CELL THERAPY FOR EBV LYMPHOMA,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$214,878"
Lymphoma,2013,NCI,5P50CA126752-07,0004,TARGETING CHEMORESISTANT TUMOR-INITIATING CELLS IN CLL,"FOSTER, AARON",BAYLOR COLLEGE OF MEDICINE,TX,"$218,925"
Lymphoma,2013,NCI,5P50CA126752-07,0006,ADMINISTRATIVE CORE,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$136,032"
Lymphoma,2013,NCI,5P50CA126752-07,9001,Clinical Research Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$139,568"
Lymphoma,2013,NCI,5P50CA126752-07,9002,Biostatistics,"LIU, HAO",BAYLOR COLLEGE OF MEDICINE,TX,"$131,070"
Lymphoma,2013,NCI,5P50CA126752-07,9003,Cell and Vector Production,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$265,400"
Lymphoma,2013,NCI,5P50CA126752-07,9004,BIOSPECIMEN AND PATHOLOGY CORE,"SHEEHAN, ANDREA",BAYLOR COLLEGE OF MEDICINE,TX,"$284,721"
Lymphoma,2013,NCI,5P50CA126752-07,7045,DEVELOPMENTAL RESEARCH PROGRAM,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$152,167"
Lymphoma,2013,NCI,5P50CA126752-07,7046,CAREER DEVELOPMENT PROGRAM,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$152,165"
Lymphoma,2013,RMAP,5R01CA174385-02,,Quantitative single-cell biomarkers of T-cells to optimize tumor immunotherapy,"VARADARAJAN, NAVIN",UNIVERSITY OF HOUSTON,TX,"$446,107"
Lymphoma,2013,FIC,5K01TW009488-02,,Developing a clinical cohort of histopathologically characterized lymphoma,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$140,175"
Lymphoma,2013,NCI,5R00CA143231-03,,Targeting the B Cell Receptor Signaling Network in Lymphoma,"IRISH, JONATHAN",VANDERBILT UNIVERSITY MED CTR,TN,"$231,136"
Lymphoma,2013,NCI,5U01CA121947-07,6759,UCLA-USC Combined Los Angeles Core Site,"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$584,310"
Lymphoma,2013,NCI,5U01CA121947-07,6761,UCSF Core Site,"KAPLAN, LAWRENCE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$584,309"
Lymphoma,2013,NCI,5R01CA170386-02,,Novel Pathogen Associated Cancers (PQ12),"GALLOWAY, DENISE",FRED HUTCHINSON CAN RES CTR,WA,"$736,412"
Lymphoma,2013,NCI,5F31CA165782-02,,"Functional analysis of cIAP2-MATL1, MALT1 and proteolytic targets in B cells","LEE, PEISHAN",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$35,813"
Lymphoma,2013,NCI,5R01CA093237-12,,Nuclear Accumulation of Cyclin D1 and Oncogenesis,"DIEHL, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$279,802"
Lymphoma,2013,NCI,1R01CA177600-01,,Regulation of CARD11 signaling in normal and dysregulated lymphocyte development,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Lymphoma,2013,NIGMS,1R01GM107058-01,,Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy,"WANG, HONGBING",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$291,650"
Lymphoma,2013,NCI,1R01CA177734-01,,Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas,"FELDMAN, ANDREW",MAYO CLINIC ROCHESTER,MN,"$329,925"
Lymphoma,2013,NCI,5P01CA119070-07,7558,Notch 1 Regulation of T-ALL Genomes,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$278,835"
Lymphoma,2013,NCI,5P01CA018029-38,5850,Nonmyeloablative Hematopoietic Cell Allotransplants,"STORB, RAINER",FRED HUTCHINSON CAN RES CTR,WA,"$314,087"
Lymphoma,2013,NHLBI,1R01HL114564-01A1,,Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes,"SAVOLDO, BARBARA",BAYLOR COLLEGE OF MEDICINE,TX,"$439,742"
Lymphoma,2013,NCI,5P01CA015396-38,5878,Targeting Cancer Stem Cells,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$322,801"
Lymphoma,2013,NCI,5P30CA046592-25,6464,Hematologic Malignancies/BMT,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$374,252"
Lymphoma,2013,NCI,5P50CA097274-12,7186,In Situ Immunization Using Nanoparticles,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$175,175"
Lymphoma,2013,NCI,5P50CA097274-12,7184,The Role of Monocytes in non-Hodgkin Lymphoma,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$263,720"
Lymphoma,2013,NCI,5P50CA097274-12,7191,Genetic Epidemiology and Function of Germline and Somatic Variants in DLBCL,"CERHAN, JAMES",UNIVERSITY OF IOWA,IA,"$257,314"
Lymphoma,2013,NCI,5P50CA097274-12,7189,Targeting JAK2 Kinase in Lymphoma,"GUPTA, MAMTA",UNIVERSITY OF IOWA,IA,"$259,311"
Lymphoma,2013,NCI,5P50CA097274-12,7192,Administration,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$130,202"
Lymphoma,2013,NCI,5P50CA097274-12,7194,Biospecimens,"DOGAN, AHMET",UNIVERSITY OF IOWA,IA,"$263,078"
Lymphoma,2013,NCI,5P50CA097274-12,7195,Biostatistics and Bioinformatics,"SMITH, BRIAN",UNIVERSITY OF IOWA,IA,"$186,402"
Lymphoma,2013,NCI,5P50CA097274-12,7197,DEVELOPMENTAL RESEARCH PROGRAM,"LENTZ, STEVEN",UNIVERSITY OF IOWA,IA,"$146,320"
Lymphoma,2013,NCI,5P50CA097274-12,7196,Clinical Research,"HABERMANN, THOMAS",UNIVERSITY OF IOWA,IA,"$284,173"
Lymphoma,2013,NCI,5P50CA097274-12,7198,CAREER DEVELOPMENT PROGRAM,"HOHL, RAYMOND",UNIVERSITY OF IOWA,IA,"$94,041"
Lymphoma,2013,NCI,5P01CA081534-13,6644,Molecular Genetics,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$521,506"
Lymphoma,2013,NCI,5P01CA081534-13,6645,Molecular Inhibition of Apoptosis Inhibitors,"REED, JOHN",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$440,176"
Lymphoma,2013,NCI,5P01CA081534-13,6646,Immune Therapy,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA,CA,"$223,339"
Lymphoma,2013,NCI,5P01CA081534-13,6647,Immune Tolerance and Stem Cell Transplantation,"GRIBBEN, JOHN",BARTS AND THE LONDON SCHOOL OF MEDICINE,,"$224,131"
Lymphoma,2013,NCI,5P01CA081534-13,6648,Mechanism-Based Pharmacologic Intervention,"PLUNKETT, WILLIAM",UT MD ANDERSON CANCER CTR,TX,"$124,641"
Lymphoma,2013,NCI,5P01CA081534-13,6649,Pharmacologic Inhibitors of Cellular Kinases and Signal Transduction,"GREVER, MICHAEL",OHIO STATE UNIVERSITY,OH,"$206,441"
Lymphoma,2013,NCI,5P01CA081534-13,6650,Administrative and Informatics,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA,CA,"$600,044"
Lymphoma,2013,NCI,5P01CA081534-13,6651,Biostatistics,"NEUBERG, DONNA",DANA-FARBER CANCER INST,MA,"$155,501"
Lymphoma,2013,NCI,5P01CA081534-13,6652,Tissue Core,"RASSENTI, LAURA",UNIVERSITY OF CALIFORNIA,CA,"$532,348"
Lymphoma,2013,NCI,5P01CA081534-13,6653,Clinical Program,"WIERDA, WILLIAM",UT MD ANDERSON CANCER CTR,TX,"$627,478"
Lymphoma,2013,NCI,5P01CA095426-12,5850,Innate Immune Therapy for B-Cell Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$359,411"
Lymphoma,2013,NCI,5P01CA095426-12,5857,MOUSE MODELING AND ANIMAL DEVELOPMENT,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$232,885"
Lymphoma,2013,NCI,5P50CA107399-08,5351,Anit-CD25 Radioimmunotherapy for Hodgkin Lymphoma,"RAUBITSCHEK, ANDREW",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$1,212,855"
Lymphoma,2013,NCI,5P50CA107399-08,5352,Adoptive T Cell Therapy For Non-Hodgkin Lymphoma,"JENSEN, MICHAEL",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$141,063"
Lymphoma,2013,NCI,5P50CA107399-08,5354,Humanized Anti-CD20-IL2 for the Treatment of CD20 Positive Lymphomas,"RAUBITSCHEK, ANDREW",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$183,669"
Lymphoma,2013,NCI,5P50CA107399-08,5353,Therapy-Related Leukemia Following Autologous Transplantation for Lymphoma,"BHATIA, RAVI",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$148,431"
Lymphoma,2013,NCI,5P50CA107399-08,5356,Administrative Core,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$114,558"
Lymphoma,2013,NCI,5P50CA107399-08,5357,Biostatistics and Research Informatics,"NILAND, JOYCE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$33,702"
Lymphoma,2013,NCI,5P50CA107399-08,5358,Tissue Bank for Cellular and Molecular Studies,"WEISS, LAWRENCE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$68,495"
Lymphoma,2013,NCI,5P50CA107399-08,5359,Biologics Manufacturing Core,"COLCHER, DAVID",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$176,915"
Lymphoma,2013,NCI,5P50CA107399-08,5360,Developmental Research Program,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$35,406"
Lymphoma,2013,NCI,5P50CA107399-08,5361,Career Development Program,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$35,406"
Lymphoma,2013,NCI,5P01CA087497-13,5109,p53 and Chemosensitivity in a Mouse Lymphoma Model,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$390,249"
Lymphoma,2013,NCI,5P01CA148600-03,5304,CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies,"DOTTI, GIANPIETRO",UT MD ANDERSON CANCER CTR,TX,"$357,151"
Lymphoma,2013,NCI,5P01CA148600-03,5309,Molecular Imaging Core,"GELOVANI, JURI",UT MD ANDERSON CANCER CTR,TX,"$162,825"
Lymphoma,2013,NCI,5P30CA016520-37,5516,Tumor Virology Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$109,294"
Lymphoma,2013,NCI,5P30CA016520-37,5521,Hematologic Malignancies Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$130,182"
Lymphoma,2013,NCI,1K23CA178183-01,,Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia,"WOYACH, JENNIFER",OHIO STATE UNIVERSITY,OH,"$173,232"
Lymphoma,2013,NCI,5P50CA094056-13,7927,Imaging NFkB Activation in HTLV Lymphoma,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$139,034"
Lymphoma,2013,NCI,1R21CA178860-01,,Development of deep proteomic sequencing platforms for molecular markers in DLBCL,"DANIAL, NIKA",DANA-FARBER CANCER INST,MA,"$190,313"
Lymphoma,2013,NCI,1R21CA178424-01,,CD164 as a novel biomarker for malignant CD4 T cells in cutaneous T cell lymphoma,"WYSOCKA, MARIA",UNIVERSITY OF PENNSYLVANIA,PA,"$208,800"
Lymphoma,2013,NCI,1R21CA178344-01,,Anthraycline-related cardiotoxicity in long-term survivors of lymphoma,"ARMENIAN, SARO",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$189,963"
Lymphoma,2013,NCI,1R01CA170006-01A1,,Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme,"GHOSH, ASISH",MAYO CLINIC ROCHESTER,MN,"$324,048"
Lymphoma,2013,NCI,5F30CA168358-02,,The interaction of Burkitt???s lymphoma cofactors EBV and Plasmodium,"WOHLFORD, ERIC",UPSTATE MEDICAL UNIVERSITY,NY,"$46,107"
Lymphoma,2013,NCI,1R01CA163910-01A1,,TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM,"HU, CHIH-CHI",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$349,638"
Lymphoma,2013,NIAID,1R01AI105000-01A1,,KSHV Lytic DNA Replication and its Control Mechanism,"VERMA, SUBHASH",UNIVERSITY OF NEVADA RENO,NV,"$335,181"
Lymphoma,2013,NCI,2R01CA120185-07,,c-Myc-regulated microRNAs in normal and pathologic cellular physiology,"MENDELL, JOSHUA",UT SOUTHWESTERN MEDICAL CENTER,TX,"$293,037"
Lymphoma,2013,NCI,2R01CA093606-11A1,,Regulation of EBV Latency by EBNA1,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$321,273"
Lymphoma,2013,NCI,1R01CA161151-01A1,,Lig4R278H contribution to HSC and IgH class switching defects and malignancies,"YAN, CATHERINE",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$361,048"
Lymphoma,2013,NCI,2R01CA130995-06A1,,"Replication Licensing in Genome Stability, Cancer and Aging","PRUITT, STEVEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$324,743"
Lymphoma,2013,NCI,1K08CA172215-01A1,,The role of GATA-3 in T-cell lymphomas,"WILCOX, RYAN",UNIVERSITY OF MICHIGAN,MI,"$178,618"
Lymphoma,2013,NCI,1R03CA173823-01A1,,Models for cumulative spatial-temporal assessment of non-Hodgkin lymphoma risk,"WHEELER, DAVID",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$76,250"
Lymphoma,2013,NINDS,1R21NS081447-01A1,,Identification of Immune modulators associated with JC virus replication,"GORDON, JENNIFER",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$193,750"
Lymphoma,2013,NCI,1R21CA173330-01A1,,Nanoparticle Enabled L-asparaginase Therapy for CLL,"ESENER, SADIK",UNIVERSITY OF CALIFORNIA,CA,"$168,563"
Lymphoma,2013,NCI,1R43CA179899-01,,Small Molecule Inhibitors of the BCL6 Oncoprotein,"ZASK, ARIE","DAYSAI BIOPHARMACEUTICALS, INC.",NY,"$280,492"
Lymphoma,2013,NHLBI,1F32HL117581-01A1,,Mechanisms of Lkb1 function in lymphocytes in the context of Kras activation,"SOUROULLAS, GEORGE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$52,190"
Lymphoma,2013,NCI,1R21CA180097-01,,(PQD2) Why is Endemic Burkitt Lymphoma Curable with Single Agent Chemotherapy?,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$165,300"
Lymphoma,2013,NCI,1R01CA180150-01,,(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition,"PETROSKI, MATTHEW",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$558,328"
Lymphoma,2013,NCI,2R44CA153676-02,,Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of,"HANSEN, STIG","CARMOT THERAPEUTICS, INC.",CA,"$987,616"
Lymphoma,2013,NHGRI,3U01CA168426-01S1,,Systems Biology of Tumor Progression and Drug Resistance,"CALIFANO, ANDREA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$520,000"
Lymphoma,2013,NIAID,4R00AI099153-02,,Regulation of EBV Latency by Chromosome Conformation,"TEMPERA, ITALO",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$249,000"
Lymphoma,2013,NCI,1F31CA180451-01,,Temporal regulation of the essential Epstein-Barr virus oncoprotein LMP1,"PRICE, ALEXANDER",DUKE UNIVERSITY,NC,"$32,501"
Lymphoma,2013,NCI,1P01CA165997-01A1,8411,Role of the UPR in myc-induced tumorigenesis,"KOUMENIS, CONSTANTINOS",UNIVERSITY OF PENNSYLVANIA,PA,"$265,266"
Lymphoma,2013,NCI,1F31CA174239-01A1,,Synergy between BCR signaling and stress response,"GOLDSTEIN, REBECCA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$42,232"
Lymphoma,2013,NCI,1P01CA165997-01A1,8412,"UPR, interferon signaling and tumorigenesis","FUCHS, SERGE",UNIVERSITY OF PENNSYLVANIA,PA,"$309,625"
Lymphoma,2013,NCI,1F31CA180449-01,,EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell Lymphoma,"O'GRADY, CHRISTINA",TULANE UNIVERSITY OF LOUISIANA,LA,"$40,311"
Lymphoma,2013,NCI,1R21CA180815-01,,Molecular profiling of HIV-associated lymphoma in the US and Malawi,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$157,700"
Lymphoma,2013,NIAID,5R01AI089882-05,,Molecular elucidation of the CBM complex in NF-kappaB activation by antigen recep,"WU, HAO",CHILDREN'S HOSPITAL CORPORATION,MA,"$364,330"
Lymphoma,2013,NCI,2R01CA096500-11A1,,Role of KSHV viral proteins in signaling and pathogenesis,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$281,108"
Lymphoma,2013,NIAID,5R01AI090113-05,,Linking IKKbeta activation to anti-autophagy in viral protein Tax-mediated oncoge,"CHENG, HUA",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$349,719"
Lymphoma,2013,NCI,1R01CA182736-01,,MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL,"GRAY, NATHANAEL",DANA-FARBER CANCER INST,MA,"$706,957"
Lymphoma,2013,NCI,3R01CA160256-02S1,,Temporal and Spatial Control of V(D)J Recombination,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$49,711"
Lymphoma,2013,NCI,5F31CA171400-02,,Mitochondrial Homeostasis in Metabolically Distinct Subsets of B-Cell Lymphoma,"STANLEY, ILLANA",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$29,530"
Lymphoma,2013,NCI,3P30CA013696-39S3,0009,LYMPHOID DVLP AND MALIGNANCIES (LDM),"O'CONNOR, OWEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$136,392"
Lymphoma,2013,NCI,1F30CA177173-01A1,,Role of Shcbp1 (mPAL) in T Cell Development and Function,"BUCKLEY, MONICA",UNIVERSITY OF VIRGINIA,VA,"$29,288"
Lymphoma,2013,NCI,3R41CA173900-01S1,,Targeting B-cell lymphoma with Leukothera,"BELINKA, BENJAMIN","ACTINOBAC BIOMED, INC.",NJ,"$108,255"
Lymphoma,2013,NCI,2R13CA124293-07,,Annual International Primary CNS Lymphoma Collaborative Group Meeting,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$7,000"
Lymphoma,2013,NCI,1F31CA183569-01,,The Role of ATF4 in Promoting c-Myc Induced Lymphomagenesis,"TAMEIRE, FEVEN",UNIVERSITY OF PENNSYLVANIA,PA,"$42,232"
Lymphoma,2013,NCI,261200800001E-52-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$1,692,154"
Lymphoma,2013,NCI,261200800001E-52-0-51,,DCTD Biopharmaceutical Development,"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$7,548,939"
Lymphoma,2013,NCI,261200800001E-52-0-105,,OCG Web Transition and Development,"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$150,000"
Lymphoma,2013,NCI,4R44CA139668-02,,Combined radio- and immunotherapy of aggressive NHL,"WEGENER, WILLIAM","IMMUNOMEDICS, INC.",NJ,"$1,137,221"
Lymphoma,2013,NCI,3R43CA153811-02S1,,Rare Protein Detection on Cell Surfaces: Ultrasensitive Detection of B-Cell Chron,"KOHNE, DAVID","JADEN BIOSCIENCE, INC.",CA,"$51,356"
Lymphoma,2013,NCI,3P50CA097274-12S1,7184,The Role of Monocytes in non-Hodgkin Lymphoma,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$107,311"
Lymphoma,2013,FIC,3D43CA153715-03S1,,Columbia-South Africa Training Program for Research on HIV-associated Malignanci,"NEUGUT, ALFRED",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$16,667"
Lymphoma,2013,NCI,3D43CA153715-03S1,,Columbia-South Africa Training Program for Research on HIV-associated Malignanci,"NEUGUT, ALFRED",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$233,333"
Lymphoma,2013,FIC,3D43CA153707-03S1,,Developing Research Capacity for AIDS Malignancy in Kenya,"REMICK, SCOT",WEST VIRGINIA UNIVERSITY,WV,"$16,667"
Lymphoma,2013,NCI,3D43CA153707-03S1,,Developing Research Capacity for AIDS Malignancy in Kenya,"REMICK, SCOT",WEST VIRGINIA UNIVERSITY,WV,"$227,985"
Lymphoma,2013,NCI,7R01CA154674-03,,Cotranslational Functions of MTOR,"JACINTO, ESTELA",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$308,569"
Lymphoma,2013,OD,3R56AI099111-01S1,,Role of ATM and RAG in maintaining genome stability during Tcra/d rearrangement.,"SKOK, JANE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$392,500"
Lymphoma,2013,NCI,3P30CA086862-13S1,8601,Cancer Immunology and Immunotherapy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$37,498"
Lymphoma,2013,NIAID,1R56AI092093-01A1,,"Fnip1 Function in Lymphocyte Development, Activation and Metabolism","IRITANI, BRIAN",UNIVERSITY OF WASHINGTON,WA,"$353,497"
Lymphoma,2013,NCI,3R01CA166325-02S1,,Mechanisms promoting translocations and mature B cell lymphomas,"WANG, JING",UNIVERSITY OF COLORADO DENVER,CO,"$45,090"
Lymphoma,2013,NIDCR,5DP5OD012160-03,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,$1
Lymphoma,2013,RMAP,5DP5OD012160-03,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,"$385,574"
Lymphoma,2013,NCI,3P30CA086862-13S2,8601,Cancer Immunology and Immunotherapy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$29,164"
Lymphoma,2013,NCI,3R37CA057138-22S1,,MYC ONCOPROTEIN FUNCTION,"EISENMAN, ROBERT",FRED HUTCHINSON CAN RES CTR,WA,"$35,000"
Lymphoma,2013,NCI,7R01CA166144-02,,Development of Therapeutic CD59 inhibitor for treating B-cell malignancies,"QIN, XUEBIN",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$223,660"
Lymphoma,2013,NIAID,1R56AI095165-01A1,,Mechanisms of Epstein-Barr Virus Persistence,"SAMPLE, JEFFERY",PENNSYLVANIA STATE UNIVERSITY,PA,"$344,361"
Lymphoma,2013,NIA,1ZIAAG000777-02,,Effect of Age on Antibody Diversity,"GEARHART, PATRICIA",NIH,,"$723,256"
Lymphoma,2013,NIA,1ZIAAG000983-05,,Long-Term Consequences of Lymphoma and its Treatment,"EGAN, JOSEPHINE",NIH,,"$42,850"
Lymphoma,2013,NEI,1ZIAEY000222-28,,Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases,"CHAN, CHI-CHAO",NIH,,"$832,099"
Lymphoma,2013,NEI,1ZIAEY000356-13,,Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis),"NUSSENBLATT, ROBERT",NIH,,"$212,753"
Lymphoma,2013,NEI,1ZIAEY000375-13,,Primary Intraocular Lymphoma and Animal Models,"NUSSENBLATT, ROBERT",NIH,,"$52,006"
Lymphoma,2013,NIAID,1ZIAAI000565-17,,Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B,"LENARDO, MICHAEL",NIH,,"$279,307"
Lymphoma,2013,NIAID,1ZIAAI000732-19,,"Clinical, Immunological and Genetic  Analyses of ALPS","LENARDO, MICHAEL",NIH,,"$477,005"
Lymphoma,2013,NIAID,1ZIAAI000733-19,,Enveloped Virus Glycoprotein/receptor Interactions,"BERGER, EDWARD",NIH,,"$284,342"
Lymphoma,2013,NIAID,1ZIAAI000858-14,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$390,144"
Lymphoma,2013,NIAID,1ZIAAI000913-12,,Epstein-Barr Virus Associated Disorders,"COHEN, JEFFREY",NIH,,"$613,553"
Lymphoma,2013,NIAID,1ZIAAI000978-08,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$490,842"
Lymphoma,2013,NIAID,1ZIAAI001059-06,,Defining New Human Immunodeficiency and Immunodysregulation Disorders,"SU, HELEN",NIH,,"$1,281,124"
Lymphoma,2013,NIAID,1ZIAAI001126-04,,B cell Receptor Dysregulation in Cancer and Autoimmune Disease,"PIERCE, SUSAN",NIH,,"$251,662"
Lymphoma,2013,NIAID,1ZIAAI001187-01,,New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior,"LENARDO, MICHAEL",NIH,,"$418,961"
Lymphoma,2013,NIAMS,1ZIAAR041148-09,,RAG and AID biology,"CASELLAS, RAFAEL",NIH,,"$3,303,331"
Lymphoma,2013,NHLBI,1ZIAHL002346-09,,"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy","WIESTNER, ADRIAN",NIH,,"$1,131,849"
Lymphoma,2013,NHLBI,1ZIAHL005076-08,,"Novel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosis","WIESTNER, ADRIAN",NIH,,"$193,552"
Lymphoma,2013,NHLBI,1ZIAHL006070-04,,Immunotherapy of low grade lymphoid malignancies,"WIESTNER, ADRIAN",NIH,,"$568,871"
Lymphoma,2013,NHGRI,1ZIAHG000123-16,,Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling,"SCHWARTZBERG, PAMELA",NIH,,"$1,585,477"
Lymphoma,2013,NCI,261200800001E-52-0-113,,Burkitt Lymphoma Genome Sequencing Project (BLGSP),"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$1,620,000"
Lymphoma,2013,NCI,1ZIABC009287-29,,Cytokines and T Cell Development,"DURUM, SCOTT",NIH,,"$636,846"
Lymphoma,2013,NCI,1ZIABC009405-19,,Regulation of Lymphocyte Proliferation and Replicative Capacity,"HODES, RICHARD",NIH,,"$289,880"
Lymphoma,2013,NCI,1ZIABC010008-18,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$393,001"
Lymphoma,2013,NCI,1ZIABC010283-16,,DNA Repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,148,001"
Lymphoma,2013,NCI,1ZIABC010301-16,,Development of Recombinant Toxins to Treat Hematologic Malignancies,"KREITMAN, ROBERT",NIH,,"$949,264"
Lymphoma,2013,NCI,1ZIABC010304-15,,Biochemical Basis of T Cell Activation,"SAMELSON, LAWRENCE",NIH,,"$1,853,723"
Lymphoma,2013,NCI,1ZIABC010621-10,,Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,"BATES, SUSAN",NIH,,"$899,393"
Lymphoma,2013,NCI,1ZIABC010715-08,,Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"WILSON, WYNDHAM",NIH,,"$100,298"
Lymphoma,2013,NCI,1ZIABC010716-08,,Phase I and II Study of BCL Family Inhibitors in Lymphoma,"WILSON, WYNDHAM",NIH,,"$200,595"
Lymphoma,2013,NCI,1ZIABC010717-08,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$100,298"
Lymphoma,2013,NCI,1ZIABC010719-08,,Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$100,298"
Lymphoma,2013,NCI,1ZIABC010728-08,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$100,298"
Lymphoma,2013,NCI,1ZIABC010885-06,,Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,"YARCHOAN, ROBERT",NIH,,"$826,639"
Lymphoma,2013,NCI,1ZIABC010888-06,,Clinical Trials of Patients with AIDS-Related Malignancies,"YARCHOAN, ROBERT",NIH,,"$1,033,298"
Lymphoma,2013,NCI,1ZIABC010957-06,,Transplant Models,"GRESS, RONALD",NIH,,"$1,067,628"
Lymphoma,2013,NCI,1ZIABC011006-06,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$1,407,103"
Lymphoma,2013,NCI,1ZIABC011007-06,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$1,407,103"
Lymphoma,2013,NCI,1ZIABC011008-06,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$1,407,103"
Lymphoma,2013,NCI,1ZIABC011064-06,,A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,"MOCK, BEVERLY",NIH,,"$196,500"
Lymphoma,2013,NCI,1ZIABC011065-06,,Preclinical Testing of HDAC and mTOR Inhibitors,"MOCK, BEVERLY",NIH,,"$393,001"
Lymphoma,2013,NCI,1ZIABC011070-06,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$560,021"
Lymphoma,2013,NCI,1ZIABC011192-05,,The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,"VAN DYKE, TERRY",NIH,,"$259,563"
Lymphoma,2013,NCI,1ZIABC011219-05,,Combination Gene Therapy and Th1Th2 Therapy,"FOWLER, DANIEL",NIH,,"$313,579"
Lymphoma,2013,NCI,1ZIABC011354-04,,BCR Signaling in ABC DLBCL,"WILSON, WYNDHAM",NIH,,"$100,298"
Lymphoma,2013,NCI,1ZIABC011374-03,,Allotransplant for DOCK8 deficiency,"HICKSTEIN, DENNIS",NIH,,"$393,515"
Lymphoma,2013,NCI,1ZIABC011413-03,,Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$42,057"
Lymphoma,2013,NCI,1ZIABC011415-03,,Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$84,115"
Lymphoma,2013,NCI,1ZIABC011471-02,,Cell-free assay technologies for the identification of active compounds,"OKEEFE, BARRY",NIH,,"$814,972"
Lymphoma,2013,NCI,1ZIABC011511-01,,Chemical Targeting of Multi-Protein Complexes,"BERNAL, FEDERICO",NIH,,"$144,902"
Lymphoma,2013,NCI,1ZIACP004410-37,,Family Studies,"TUCKER, MARGARET",NIH,,"$3,708,348"
Lymphoma,2013,NCI,1ZIACP005782-19,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$342,436"
Lymphoma,2013,NCI,1ZIACP010125-18,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,176,669"
Lymphoma,2013,NCI,1ZIACP010131-18,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"BERRINGTON, AMY",NIH,,"$2,853,387"
Lymphoma,2013,NCI,1ZIACP010150-14,,"Infections, immunity, and inflammation in cancer","ENGELS, ERIC",NIH,,"$1,215,369"
Lymphoma,2013,NCI,1ZIACP010170-13,,Multidisciplinary Studies of Hematopoietic Malignancies,"MORTON, LINDSAY",NIH,,"$868,892"
Lymphoma,2013,NCI,1ZIACP010176-13,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$3,542,746"
Lymphoma,2013,NCI,1ZIACP010212-04,,Molecular mechanisms of infection-related cancer,"RABKIN, CHARLES",NIH,,"$135,000"
Lymphoma,2013,NCI,1ZIACP010214-04,,Microbes and Human Malignancies,"GOEDERT, JAMES",NIH,,"$383,149"
Lymphoma,2013,NCI,1ZIASC000550-33,,Lymphoma Disease Discovery and Defintion,"JAFFE, ELAINE",NIH,,"$1,120,044"
Lymphoma,2013,NCI,1ZIASC004002-44,,IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"WALDMANN, THOMAS",NIH,,"$1,939,404"
Lymphoma,2013,NCI,1ZIASC006741-21,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$300,893"
Lymphoma,2013,NCI,1ZIASC010282-16,,Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),"ARTHUR, DIANE",NIH,,"$101,612"
Lymphoma,2013,NCI,1ZIASC010288-16,,Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,"FOWLER, DANIEL",NIH,,"$627,158"
Lymphoma,2013,NCI,1ZIASC010356-14,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$443,193"
Lymphoma,2013,NCI,1ZIASC010357-14,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$1,047,882"
Lymphoma,2013,NCI,1ZIASC010378-13,,Activation of Proto-Oncogenes by Chromosomal Translocation,"APLAN, PETER",NIH,,"$573,096"
Lymphoma,2013,NCI,1ZICBC010934-06,,Immune reconstitution following autologous and allogeneic stem cell transplant,"HAKIM, FRANCES",NIH,,"$816,678"
Lymphoma,2013,NCI,1ZICBC011029-06,,Preclinical development and clinical monitoring of adoptive immune therapy,"HAKIM, FRANCES",NIH,,"$204,170"
Lymphoma,2013,NCI,1ZICBC011040-06,,Molecular Profiling of Clinical Specimens,"EDELMAN, DANIEL",NIH,,"$1,716,743"
Lymphoma,2013,NCI,1ZICBC011079-06,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$444,657"
Lymphoma,2013,NCI,1ZICBC011093-06,,Flow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$226,251"
Lymphoma,2013,NCI,1ZICBC011237-05,,CIP Genomics Core,"OHUIGIN, COLM",NIH,,"$904,241"
Lymphoma,2013,NCI,1ZICSC010353-14,,Experimental Therapeutics of Pediatric Hematopoietic Malignancies,"WAYNE, ALAN",NIH,,"$666,058"
Lymphoma,2013,NCI,1ZIDBC010963-06,,ETIB Clinical Research Core,"GRESS, RONALD",NIH,,"$2,268,710"
Lymphoma,2013,NCI,1ZIDBC010990-06,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$6,652,159"
Lymphoma,2013,NCI,1ZIEBC010843-07,,Medical Oncology Fellowship Program,"FOJO, ANTONIO",NIH,,"$6,279,868"
Lymphoma,2013,NCI,1ZIEBC011241-05,,Hematopathology Fellowship,"JAFFE, ELAINE",NIH,,"$560,021"
Lymphoma,2013,NCI,1ZIGBC010856-07,,Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,"CUSTER, MARY",NIH,,"$20,198,842"
